Login / Signup

Evaluation of the Safety of a Plant-Based Infant Formula Containing Almonds and Buckwheat in a Neonatal Piglet Model.

Fernanda RosaBrooke YelvingtonNathan TerryPatricia TrippHoy E PittmanBobby L FayTaylor J RossJames D SikesJessica B FlowersFabiana Bar-YosephLaxmi Yeruva
Published in: Nutrients (2022)
A randomized neonatal piglet trial was conducted to evaluate the safety and the effects of a plant-based formula containing almonds and buckwheat as the main ingredients on growth and plasma parameters. From postnatal day (PND) 2 to 21, the piglets were fed a dairy-based milk formula (Similac Advance) or a plant-based formula (Else Nutrition) and all piglets were euthanized at day 21. No diarrhea was observed after PND 8 and all the piglets completed the trial. Body growth, kcal intake, the complete plasma count parameters and hematological parameters were within the reference range in both groups. Organ growth and development was similar between the two groups. Plasma glucose was higher in the dairy-based-fed piglets relative to the plant-based at 2 weeks of age. Liver function biomarkers levels were greater in the plasma of the plant-based compared to the dairy-based fed group. In addition, calcium levels were higher in the plant-based fed piglets at 1 week of age. Thus, the plant-based formula tested in this study was well tolerated by the piglets and supported similar growth compared to dairy-based milk formula. Therefore, the results support the safety of the tested plant-based infant formula during the neonatal period in comparison to the dairy-based formula fed group.
Keyphrases
  • human milk
  • clinical trial
  • study protocol
  • type diabetes
  • randomized controlled trial
  • blood pressure
  • skeletal muscle
  • body mass index
  • low birth weight
  • phase iii
  • plant growth
  • blood glucose
  • peripheral blood
  • open label